|
Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Mar. 30, 2013
|
Mar. 24, 2012
|
Mar. 30, 2013
|
Mar. 24, 2012
|
|
| Revenues: | ||||
| Product sales | $ 518,014 | $ 388,085 | $ 1,053,216 | $ 780,181 |
| Service and other revenues | 94,649 | 83,080 | 190,809 | 163,695 |
| Total revenues | 612,663 | 471,165 | 1,244,025 | 943,876 |
| Costs and expenses: | ||||
| Cost of product sales | 208,278 | 154,423 | 431,771 | 286,367 |
| Cost of product sales - amortization of intangible assets | 75,733 | 44,341 | 151,020 | 90,512 |
| Cost of service and other revenues | 49,326 | 46,291 | 100,235 | 91,517 |
| Research and development | 49,621 | 29,297 | 101,130 | 57,639 |
| Selling and marketing | 88,614 | 78,539 | 183,057 | 155,999 |
| General and administrative | 64,233 | 41,843 | 118,624 | 88,338 |
| Amortization of intangible assets | 28,667 | 16,629 | 57,193 | 31,471 |
| Contingent consideration - compensation expense | 29,388 | 18,121 | 58,874 | 28,562 |
| Contingent consideration - fair value adjustments | 799 | 43,188 | 10,839 | 48,310 |
| Gain on sale of intellectual property | (12,424) | (53,884) | (12,424) | |
| Restructuring and divestiture charges | 12,462 | 783 | 16,395 | 692 |
| Costs and expenses, total | 607,121 | 461,031 | 1,175,254 | 866,983 |
| Income from operations | 5,542 | 10,134 | 68,771 | 76,893 |
| Interest income | 207 | 590 | 467 | 1,252 |
| Interest expense | (76,049) | (28,512) | (148,130) | (58,021) |
| Debt extinguishment loss | (3,247) | (42,347) | (3,247) | (42,347) |
| Other (expense) income, net | (201) | 1,527 | 1,038 | 3,519 |
| Loss before income taxes | (73,748) | (58,608) | (81,101) | (18,704) |
| (Benefit) provision for income taxes | (22,644) | (18,335) | (33,115) | 757 |
| Net (loss) income | $ (51,104) | $ (40,273) | $ (47,986) | $ (19,461) |
| Net loss per common share: | ||||
| Basic | $ (0.19) | $ (0.15) | $ (0.18) | $ (0.07) |
| Diluted | $ (0.19) | $ (0.15) | $ (0.18) | $ (0.07) |
| Weighted average number of shares outstanding: | ||||
| Basic | 268,175 | 263,900 | 267,259 | 263,309 |
| Diluted | 268,175 | 263,900 | 267,259 | 263,309 |
| X | ||||||||||
|
- Definition
Represents the amount of contingent consideration expense recorded in the respective reporting period. No definition available.
|
| X | ||||||||||
|
- Definition
Amount represents the difference between the fair value of the payments made and the carrying amount of the debt at the time of extinguishment. For debt instruments within the scope of the Cash Conversion Subsections of ASC 470, this element represents the difference between the fair value of the liability component of the debt instrument immediately before extinguishment and the sum of the net carrying amount of the liability component and any unamortized debt issuance costs at the time of extinguishment. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the amount of any change, including any differences arising upon settlement, recognized during the reporting period in the value of a liability, arising from an item of contingent consideration, assumed in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of expense recognized in the current period that reflects the allocation of the costs of intangible assets over the expected benefit period of such assets. This element applies only to intangible assets used in the production of goods. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs related to services rendered by an entity during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total costs of sales and operating expenses for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The excess or deficiency of net proceeds from sale in the period compared to carrying value of intangible assets as of consummation date of the sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Income derived from investments in debt securities and on cash and cash equivalents the earnings of which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount charged against earnings in the period for incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding asset retirement obligations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|